SILUTS-D8

SILUTS-D8 is the brand the house features, and the featuring is a matter of attention rather than a licence to speak loosely. The capsule contains silodosin 8 mg and dutasteride 0.5 mg. The published account of the pairing is plain: the two medicines act in different ways. Silodosin relaxes the muscle around the bladder outlet and prostate so urine can pass more easily. Dutasteride addresses gland size. The indications on the page are an enlarged prostate in men, and easier passage of urine by that relaxation. The dose is as directed by the physician. The pack is 10 × 10 capsules. The MRP is ₹415. A page that cannot repeat those sentences without adding a new percentage has already failed the house style.

The SILUTS family makes the danger of a vague order obvious. SILUTS-8 is silodosin 8 mg alone, taken after a meal, MRP ₹315, pack of 10 capsules. SILUTS-4 is silodosin 4 mg, written for moderate renal impairment, also after a meal, MRP ₹195. SILUTS-D8 is the only one of the three that brings dutasteride. A letter that says “SILUTS” is not an order. A letter that says “the 8 mg” is still not an order, because two packs contain 8 mg of silodosin and only one of them contains dutasteride. Say SILUTS-D8, say the pack of 10 × 10, and say whether the physician’s direction is what you are supplying against.

There is a second combination in urology, and it is not this one. TALUTS-D pairs tamsulosin modified release 0.4 mg with dutasteride 0.5 mg in a film-coated bi-layer tablet. Both combinations include dutasteride. They do not include the same alpha blocker, they do not share a dose line, and they do not share an MRP. TALUTS-D is ₹275. Putting the two “D” suffixes in one sentence without the first half of each name is how a store room fills the wrong bin. The sidebar lists both families so the eye can do what a hurried voice will not.

Nothing on this page borrows the house’s figures from UGAXIS-P, TALUTS 0.4, or LHRH 22.5. No Q-max, no 76 percent, no PSA decline. Those numbers have their own brands. SILUTS-D8 is allowed its own description of two actions and its featured flag. It is not allowed a composite “prostate portfolio” claim. If a presentation needs one slide, the slide is the composition, the pack, the MRP, and the sentence about muscle and gland size. The photograph of the pack is the client’s photograph. Use that, not a redraw.

Who the page is for

The page is for a clinician who already manages enlarged prostate and wants the published pairing in one place, and for a stockist who must not ship the single-agent capsule by mistake. It is not a patient leaflet and it is not a comparison trial against surgery or against TALUTS-D. Men’s health, in the house’s map, also includes the oral spray and the nephrology tablet. They are not adjuncts you add because the cart allows it. Add SILUTS-D8 when SILUTS-D8 is the brand. The Hyderabad office can discuss quantity. It should not have to recover the strength from a nickname.